Bench to Bedside: Understanding Regulatory Pathways for Delivering Health Technology to Patients

Dr Hugh Harvey

Managing Director at Hardian Health

He has transitioned from the NHS, where he was a consultant radiologist at Guys & St Thomas’ and a Royal College of Radiologists informatics committee and AI advisory board  member, into industry, having been Lead for Regulatory Affairs at Babylon Health and the clinical director at Kheiron Medical, an AI company focussed on deep learning in breast cancer. He was co-chair of the  government Topol Review into AI in healthcare in 2018, and has worked with several think-tanks and government bodies on the regulatory aspects of deploying AI in clinical settings.